| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-15 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-13 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-09 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.19 | 8e-09 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-09 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-09 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |